quality of life Archives - Drugs in Context

Real-world assessment of effectiveness and safety of filgotinib in 286 patients with ulcerative colitis in 9 UK centres

David Young, Sohail Rahmany, Deborah Taylor, Emma Davis, Michael Colwill, Sonia Kalyanji Mehta, Roisin Campbell, Karl Hazel, Karishma Sethi-Arora, Susan Ritchie, Ashley I Heinson, Helen Moyses, Keith Bodger, Emma Johnston, Lucy Hicks, Anjan Dhar, Jimmy Limdi, Rachel Cooney, John Paul Seenan, Kamal Patel, Alissa Walsh, Fraser Cummings

Article Type

Original Research

Published

29 Jan 2025

This article reports the real-world
experience of 286 patients with ulcerative colitis treated with filgotinib as part of their routine clinical care in 9 UK centres.

Evaluation of the criteria for renewal of LHRH agonists in patients with prostate cancer: results of the ANAREN Study

Jesús Calleja-Escudero, Víctor Barrondo, Andrés Rodriguez-Alonso, Francisco Gómez-Veiga, Joan Bestard, Antonio Gómez-Caamaño, Anne-Sophie Grandoulier, Maria Pérez-Sampietro, Venancio Chantada-Abal, Raúl Poza de Celis, on behalf of ANAREN Study Group

Article Type

Original Research

Published

19 Jun 2024

This study aims to determine the percentage of patients whose initial luteinizing hormone-releasing hormone agonists prescription was renewed during follow-up, how many changed formulation and how their quality of life evolved.

Understanding treatment goals and their application in clinical trial design for patients with Alzheimer disease and caregivers

David Gómez-Ulloa, M Chris Runken, Wilton I Rodriguez, Basilio Hernández, Montserrat Chivite, E Anne Davis, Paul Nisbet

Article Type

Original Research

Published

29 Apr 2024

The goal of the present study was to survey patients with AD and caregivers to establish what they considered to be the most important treatment goals, thereby providing data for the systematic incorporation of these goals into Alzheimer disease clinical trials.

Fentanyl in cancer pain management: avoiding hasty judgments and discerning its potential benefits

Arturo Cuomo

Article Type

Review

Published

14 Dec 2023

This review provides an update on the management of breakthrough cancer pain with fentanyl, with consideration of safety, as it remains an important tool in the treatment of cancer pain.

Health-related quality of life and clinical complexity of a real-life cohort of patients with advanced HR+/HER2– breast cancer treated with CDK4/6 inhibitors and endocrine therapy

Barbara Tagliaferri, Ludovica Mollica, Raffella Palumbo, Claudia Leli, Alberto Malovini, Matteo Terzaghi, Erica Quaquarini, Cristina Teragni, Stefano Maccarone, Andrea Premoli, Federico Sottotetti

Article Type

Original Research

Published

20 Jun 2023

This real-life study investigated the link between clinical complexity and quality of life of patients with HR+/HER2– advanced breast cancer treated with CDK4/6 inhibitors.